End-of-day quote
Korea S.E.
18:00:00 2024-05-16 EDT
|
5-day change
|
1st Jan Change
|
8,200
KRW
|
+0.86%
|
|
-26.26%
|
-12.11%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
-
|
408,421
|
822,627
|
732,562
|
-
|
-
|
Enterprise Value (EV)
2 |
-
|
395.4
|
771.5
|
673.5
|
615.1
|
550.7
|
P/E ratio
|
0.88
x
|
14.2
x
|
21.2
x
|
16
x
|
11.1
x
|
8.96
x
|
Yield
|
-
|
-
|
-
|
0.65%
|
0.81%
|
0.88%
|
Capitalization / Revenue
|
-
|
5.01
x
|
6.95
x
|
4.89
x
|
3.77
x
|
3.1
x
|
EV / Revenue
|
-
|
4.85
x
|
6.52
x
|
4.5
x
|
3.16
x
|
2.33
x
|
EV / EBITDA
|
-
|
14
x
|
16.3
x
|
10.9
x
|
7.37
x
|
5.39
x
|
EV / FCF
|
-
|
27.8
x
|
32.4
x
|
23.4
x
|
12.1
x
|
8.42
x
|
FCF Yield
|
-
|
3.6%
|
3.09%
|
4.28%
|
8.28%
|
11.9%
|
Price to Book
|
-
|
7.16
x
|
8.29
x
|
5.2
x
|
3.57
x
|
2.6
x
|
Nbr of stocks (in thousands)
|
-
|
87,927
|
88,170
|
89,337
|
-
|
-
|
Reference price
3 |
2,675
|
4,645
|
9,330
|
8,200
|
8,200
|
8,200
|
Announcement Date
|
3/18/22
|
3/7/23
|
2/8/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
51.06
|
81.48
|
118.4
|
149.8
|
194.6
|
236.4
|
EBITDA
1 |
-
|
28.32
|
47.42
|
61.62
|
83.43
|
102.2
|
EBIT
1 |
-
|
27.03
|
46.04
|
58.3
|
80.75
|
99.08
|
Operating Margin
|
-
|
33.17%
|
38.9%
|
38.93%
|
41.5%
|
41.91%
|
Earnings before Tax (EBT)
1 |
-
|
18.21
|
47.72
|
58.7
|
83.55
|
103.5
|
Net income
1 |
-
|
16.59
|
38.83
|
45.5
|
65.53
|
81.34
|
Net margin
|
-
|
20.35%
|
32.81%
|
30.38%
|
33.68%
|
34.41%
|
EPS
2 |
3,025
|
327.0
|
441.0
|
514.0
|
736.7
|
915.4
|
Free Cash Flow
3 |
-
|
14,238
|
23,846
|
28,825
|
50,940
|
65,375
|
FCF margin
|
-
|
17,472.99%
|
20,146.7%
|
19,245.53%
|
26,181.26%
|
27,654.4%
|
FCF Conversion (EBITDA)
|
-
|
50,267.63%
|
50,288.62%
|
46,774.85%
|
61,054.74%
|
63,992.76%
|
FCF Conversion (Net income)
|
-
|
85,842.48%
|
61,405.2%
|
63,351.65%
|
77,731.44%
|
80,372.51%
|
Dividend per Share
2 |
-
|
-
|
-
|
53.67
|
66.25
|
72.25
|
Announcement Date
|
3/18/22
|
3/7/23
|
2/8/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
30.5
|
26.38
|
30.2
|
22.57
|
35
|
40.65
|
46.35
|
EBITDA
1 |
-
|
-
|
-
|
15.9
|
16.2
|
16.8
|
17.5
|
EBIT
1 |
-
|
9.532
|
10.49
|
6.634
|
12.7
|
16.55
|
22.4
|
Operating Margin
|
-
|
36.13%
|
34.75%
|
29.4%
|
36.29%
|
40.71%
|
48.33%
|
Earnings before Tax (EBT)
1 |
-
|
9.592
|
12.93
|
6.937
|
15.3
|
17.7
|
18.5
|
Net income
1 |
-
|
8.722
|
9.286
|
5.924
|
10
|
10
|
21
|
Net margin
|
-
|
33.06%
|
30.75%
|
26.25%
|
28.57%
|
24.6%
|
45.31%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/11/23
|
11/10/23
|
2/8/24
|
5/10/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
13
|
51.1
|
59.1
|
117
|
182
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
2 |
-
|
14,238
|
23,846
|
28,825
|
50,940
|
65,375
|
ROE (net income / shareholders' equity)
|
-
|
40%
|
49.7%
|
37.8%
|
35.5%
|
33.4%
|
ROA (Net income/ Total Assets)
|
-
|
27.3%
|
34.2%
|
24.7%
|
28%
|
26.3%
|
Assets
1 |
-
|
60.7
|
113.5
|
184.6
|
233.9
|
309.6
|
Book Value Per Share
3 |
-
|
649.0
|
1,126
|
1,578
|
2,295
|
3,152
|
Cash Flow per Share
3 |
-
|
-
|
295.0
|
650.0
|
790.0
|
-
|
Capex
1 |
-
|
0.54
|
2.11
|
3.5
|
3.06
|
5.38
|
Capex / Sales
|
-
|
0.67%
|
1.78%
|
2.34%
|
1.57%
|
2.27%
|
Announcement Date
|
3/18/22
|
3/7/23
|
2/8/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
8,200
KRW Average target price
13,429
KRW Spread / Average Target +63.76% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.11% | 539M | | +73.24% | 12.42B | | -19.09% | 7.81B | | +5.88% | 6.4B | | +13.24% | 5.45B | | +38.48% | 5.01B | | -17.30% | 4.84B | | -19.78% | 4.19B | | -29.53% | 2.69B | | +47.29% | 2.39B |
Medical Equipment
|